BIOMAT Database Logo BIOMAT Database Logo

HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1. 2013

Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
Department of Otolaryngology and Head and Neck Surgery, University Medical Center Hamburg Eppendorf, Germany.

OBJECTIVE Despite the comparably high cure rates observed for HPV-positive HNSCC, there is still a great need for specific tumor radiosensitization due to the often severe side effects resulting from intense radiochemotherapy. We recently demonstrated that HPV-positive HNSCC cell lines are characterized by a defect in DNA double-strand break repair associated with a pronounced G2-arrest. Here we tested whether abrogation of this radiation-induced G2-arrest by the inhibition of Chk1 results in specific radiosensitization of HPV-positive HNSCC cells. METHODS Experiments were performed with five HPV and p16-positive (93-VU-147T, UM-SCC-47, UT-SCC-45, UD-SCC-2, UPCI-SCC-154) and two HPV and p16-negative HNSCC cell lines, as well as two normal human fibroblast strains. Chk1 was inhibited by the selective inhibitor PF-00477736. Cell cycle distribution was determined by flow cytometry, Chk1-activity via Western blot and cell survival by colony formation assay. RESULTS With the exception of UPCI-SCC-154, the inhibition of Chk1 was found to abolish the pronounced radiation-induced G2-arrest in all HPV-positive cells utilized. All tumor cell lines that demonstrated the abrogation of G2-arrest also demonstrated radiosensitization. Notably, in G1-arrest-proficient normal human fibroblasts no radiosensitization was induced. CONCLUSIONS Abrogation of the G2 checkpoint through the inhibition of Chk1 may be used to selectively increase the cellular radiosensitivity of HPV-positive HNSCC without affecting the surrounding normal tissue.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071877 Checkpoint Kinase 1 A serine/threonine-specific protein kinase which is encoded by the CHEK1 gene in humans. Checkpoint kinase 1 (also known as Chk1) coordinates DNA damage response and cell cycle checkpoint response. Under these conditions, activation of Chk1 results in the initiation of cell cycle checkpoints, cell cycle arrest, DNA repair and cell death, to prevent damaged cells from progressing through the cell cycle. Checkpoint-1 Kinase,Chk1 Kinase,Chk1 Protein Kinase,Protein Kinase, Chk1
D000077195 Squamous Cell Carcinoma of Head and Neck The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. HNSCC,Head And Neck Squamous Cell Carcinomas,Hypopharyngeal Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Oral Squamous Cell Carcinomas,Oral Tongue Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma,Squamous Cell Carcinoma of Larynx,Squamous Cell Carcinoma of the Larynx,Squamous Cell Carcinoma of the Mouth,Squamous Cell Carcinoma of the Nasal Cavity,Carcinoma, Squamous Cell of Head and Neck,Head and Neck Squamous Cell Carcinoma,Squamous Cell Carcinoma of the Head and Neck,Squamous Cell Carcinoma, Head And Neck
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53

Related Publications

Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
HPV-positive HNSCC cell lines show strongly enhanced radiosensitivity after photon but not after carbon ion irradiation.
October 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
HPV-negative and HPV-positive HNSCC cell lines show similar numerical but different structural chromosomal aberrations.
November 2019, Head & neck,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines.
December 2017, Oncotarget,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines.
September 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC.
September 2021, Cancer immunology, immunotherapy : CII,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC.
August 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
Chk1 inhibitor-induced DNA damage increases BFL1 and decreases BIM but does not protect human cancer cell lines from Chk1 inhibitor-induced apoptosis.
January 2022, American journal of cancer research,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
Histopathologic findings of HPV and p16 positive HNSCC.
September 2010, The Laryngoscope,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
Telomerase positive human diploid fibroblasts are resistant to replicative senescence but not premature senescence induced by chemical reagents.
January 2002, Biogerontology,
Chia-Jung Busch, and Malte Kriegs, and Simon Laban, and Silke Tribius, and Rainald Knecht, and Cordula Petersen, and Ekkehard Dikomey, and Thorsten Rieckmann
The HPV transcriptome in HPV16 positive cell lines.
January 2011, Molecular and cellular probes,
Copied contents to your clipboard!